This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the treatment landscape for alopecia areata with a focus on therapies from Incyte, Concert, Lilly, Pfizer, and Equillium

Ticker(s): INCY, CNCE, LLY, EQ, PFE

Who's the expert?

Institution: Mount Sinai

  • Clinical Instructor of Dermatology at Weill Cornell and Mount Sinai. 
  • Treats 30 patients with alopecia areata
  • Clinical interests include autoimmune and autoinflammatory skin conditions with a specialty in MOHS micrographic surgery.

Interview Goal
A look at how the treatment landscape for severe alopecia areata has changed since the approval for Olumiant

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.